Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Oxford Nanopore Technologies (LSE:ONT) in Focus as Upcoming Investor Conference Participation Puts London Investors on Alert

The latest corporate development has givenMarket Participantsa fresh reason to assess Oxford Nanopore Technologies. Announcements can influence valuation through several channels: an immediate change in expected cash flow, a shift in perceived risk, or a reassessment of management’s ability to execute. In this case, …

Ankur Sharma | 04 November 2026

Smith & Nephew (LSE:SN.) in Focus as Third-Quarter 2026 Trading Update Puts London Investors on Alert

The latest corporate development has givenMarket Participantsa fresh reason to assess Smith & Nephew. Announcements can influence valuation through several channels: an immediate change in expected cash flow, a shift in perceived risk, or a reassessment of management’s ability to execute. In this case, …

Ankur Sharma | 04 November 2026

Why Arecor Therapeutics PLC (LSE:AREC) Is on London Investors’ Radar: What Matters Next on 4 November 2026

• Share-price direction on 4 November should be assessed against actual turnover,Liquidityand published company developments.

Ankur Sharma | 04 November 2026

Why EDX Medical Group PLC (LSE:EDX) Is on London Investors’ Radar: What Matters Next on 4 November 2026

• Share-price direction on 4 November should be assessed against actual turnover,Liquidityand published company developments.

Ankur Sharma | 04 November 2026

Why Feedback plc (LSE:FDBK) Is on London Investors’ Radar: What Matters Next on 4 November 2026

• Share-price direction on 4 November should be assessed against actual turnover,Liquidityand published company developments.

Ankur Sharma | 04 November 2026

Why HemoGenyx Pharmaceuticals Plc (LSE:HEMO) Is on London Investors’ Radar: What Matters Next on 4 November 2026

• Share-price direction on 4 November should be assessed against actual turnover,Liquidityand published company developments.

Ankur Sharma | 04 November 2026

Why IXICO Plc (LSE:IXI) Is on London Investors’ Radar: What Matters Next on 4 November 2026

• Share-price direction on 4 November should be assessed against actual turnover,Liquidityand published company developments.

Ankur Sharma | 04 November 2026

Why MedPal AI Plc (LSE:MPAL) Is on London Investors’ Radar: What Matters Next on 4 November 2026

• Share-price direction on 4 November should be assessed against actual turnover,Liquidityand published company developments.

Ankur Sharma | 04 November 2026

Why Sareum Holdings plc (LSE:SAR) Is on London Investors’ Radar: What Matters Next on 4 November 2026

• Share-price direction on 4 November should be assessed against actual turnover,Liquidityand published company developments.

Ankur Sharma | 04 November 2026

Why Eden BioSolutions PLC (LSE:EDEN) Is on London Investors’ Radar: What Matters Next on 4 November 2026

• Share-price direction on 4 November should be assessed against actual turnover,Liquidityand published company developments.

Ankur Sharma | 04 November 2026
Support

Hi! How can we help you today?

Loading…